TG Therapeutics | TGTX - Market Capitalization

Stock Price
30.90
Daily Change
1.24 4.18%
Monthly
0.32%
Yearly
8.31%
Q1 Forecast
28.61

TG Therapeutics reported $4.78B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 391.49B 12.34B Feb/2026
Alaunos Therapeutics USD 5M 2M Sep/2025
Amgen USD 201.45B 25.2B Feb/2026
Ardelyx USD 1.33B 390M Sep/2025
Arrowhead Research USD 8.04B 973M Feb/2026
Bayer EUR 27.23B 2.14B Sep/2025
Biogen USD 27.01B 1.19B Feb/2026
Corcept Therapeutics USD 3.82B 161M Feb/2026
Curis USD 75M 36M Dec/2023
Gilead Sciences USD 183.59B 31.31B Feb/2026
Infinity Pharmaceuticals USD 19M 5M Jun/2023
J&J USD 500.24B 67.44B Dec/2025
Novartis USD 265.66B 9.48B Sep/2025
Novavax USD 684M 43M Sep/2023
PTC Therapeutics USD 5.36B 744M Feb/2026
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
TG Therapeutics USD 4.58B 153M Feb/2026
Verastem USD 205M 17M Sep/2023
Vertex Pharmaceuticals USD 120.12B 5.09B Feb/2026